SciCann Therapeutics
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
SciCann Therapeutics | TBD | Biotechnology & Biopharmaceutical | Clinical use (of cognitive, psychological, psychiatric, inc. early diagnosis) | Biochemical: pharmacological drugs (Developing drugs) |
SciCann Therapeutics is a Canadian-Israeli specialty pharmaceutical company, dedicated to the development and commercialization of novel and disruptive pharmaceutical products that target and modulate the endocannabinoid system.
SciCann Therapeutics is active in the fields of oncology, pain management, neurodegenerative diseases and inflammatory disorders, and develops a line of proprietary products for the treatment of chosen life- threatening conditions that present a high level of unmet need.
SciCann Therapeutics holds a diversified portfolio of IP and ownerships in ventures operating in the cutting edge technology of cannabinoid science, and maintains a wide network of strategic and synergistic collaborations with leading research institutes and commercial companies in the space.